VEGFA and familial pancreatic carcinoma: MiR-145 is known to be associated with gemcitabine resistance in pancreatic cancer and it is believed that ErbB and VEGF signaling biological pathways were activated (Skrypek et al., 2015; Zhou et al., 2016).